Nasdaq

Motus GI Announces First Upper GI Patient Procedure for FDA Cleared Pure-Vu® EVS Gastro

FORT LAUDERDALE, Fla., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes and ...
Yahoo Finance

Motus GI Announces Improvement of Pure-Vu® EVS System for Use in Upper Gastrointestinal (GI) Bleeding Procedures Following Successful Pre-Clinical Tests

Pre-clinical tests show enhanced functionality of Pure-Vu EVS that can enable physicians to overcome common visualization challenges encountered during emergency upper GI bleeding procedures ...
Seeking Alpha

Motus GI's Pure-Vu Gen 4 Gastro device shows promising results in clinical evaluation for upper GI bleeding procedures

May 17, 2023, 10:02 AM ETMotus GI Holdings, Inc. (MOTS) StockBy: SA News Team ...
Medscape

Low Rate of Aspiration With GLP-1s During Upper GI Endoscopy

New data from the Mayo Clinic provide added reassurance that the rate of pulmonary aspiration during upper gastrointestinal (GI) endoscopy is low in patients taking a glucagon-like peptide 1 (GLP-1) ...
FierceBiotech

FDA OKs EndoSound device that adds ultrasound to any upper GI endoscope

In the wake of warnings from the FDA about safety issues associated with certain ultrasound-equipped endoscopes, EndoSound has secured an agency clearance for a device designed to avoid those issues.
Healio

A clear liquid diet prior to GI endoscopy may be ‘more important’ than holding GLP-1RAs

Please provide your email address to receive an email when new articles are posted on . GLP-1RA use prior to upper endoscopy was linked to increased risk for retained gastric contents. A 24-hour clear ...